18 May 2013
Keywords: la, jolla/leo, pharmaceutical, ljp, deal, jolla, pharmaceuticals
Article | 25 September 1995
- La Jolla Pharmaceuticals has licensed marketing rights in Europe and
the Middle East for LJP 394, its candidate drug for lupus ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
17 May 2013
© 2013 thepharmaletter.com